EUVIMEDEUVIMED entdecken
Multizentrische Studie

Does valve size impact hemodynamic, left ventricular mass regression, and prosthetic valve deterioration with a sutureless aortic valve?

Gabriel S Aldea, Christopher R Burke, Theodor Fischlein, David A Heimansohn, Axel Haverich, Rakesh M Suri, Niv Ad

The Journal of Thoracic and Cardiovascular Surgery · 2024

DOI: 10.1016/j.jtcvs.2023.01.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Gabriel S Aldea und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, University of Washington, Seattle, Wash. Electronic address: aldea@uw.edu. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Aortic Valve, Hemodynamics, Prosthesis Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To assess the mid-term clinical outcomes, hemodynamics, left ventricular (LV) mass regression, and structural valve deterioration (SVD) in patients implanted with the Perceval aortic sutureless valve across valve sizes. METHODS: Data were obtained from a multicenter European trial and a US Investigational Device Exemption trial. Echocardiography data were analyzed by an echocardiography core lab. A mixed-effects regression model was used to assess relationships between hemodynamic outcomes, time from the procedure, and valve sizes. The Valve Academic Research Consortium (VARC)-3 definition for bioprosthetic valve failure was applied. RESULTS: A Perceval sutureless valve was implanted in 970 patients. The median patient age was 77.8 years, 57.2% were female, the median Society of Thoracic Surgeons predicated risk of mortality was 3.3% (range, 2.1%-6.2%), and 33.4% had a concomitant procedure. The median clinical follow-up was 45.7 months (range, 28.2-76.1 months). Small and medium valves were implanted more commonly in women than in men (16.9% vs 1.9% for small and 55.1% vs 19.5% for medium; P 0.8). Significant LV mass regression was documented regardless valve sizes, plateaued at -9.1% at 5 years. Freedom from SVD and reintervention were 95.2% and 96.3%, respectively, at 5 years and were independent of implanted valve size (P = .22). The VARC-3 stage 3 bioprosthetic valve failure rate was low, 2.8% at 5 years. CONCLUSIONS: The Perceval valve demonstrated low and stable mean gradients, significant LV mass regression, and low SVD and reintervention rates across all valve sizes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisAortic ValveHemodynamicsProsthesis DesignHeart Valve Prosthesis ImplantationBioprosthesisAortic Valve StenosisProsthesis FailureHumansFemaleMaleAgedAged, 80 and overTreatment OutcomeTime FactorsRisk FactorsVentricular RemodelingEuropeVentricular Function, LeftUnited StatesSutureless Surgical Procedures

Stichwörter der Autor:innen

VARC-3 bioprostheticsutureless valve hemodynamicvalve failureventricular mass regression

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, University of Washington, Seattle, Wash. Electronic address: aldea@uw.edu.
  • Division of Cardiothoracic Surgery, University of Washington, Seattle, Wash.
  • Department of Cardiac Surgery, Klinikum Nürnberg, Paracelsus Medical University, Nürnberg, Germany.
  • St Vincent Heart Center of Indiana, Indianapolis, Ind.
  • Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery, Medizinische Hochschule Hannover, Hannover, Germany.
  • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi and Cleveland Clinic Foundation, Cleveland, Ohio.

Zitieren

APA

Aldea, G. S., Burke, C. R., Fischlein, T., Heimansohn, D. A., Haverich, A., Suri, R. M., & Ad, N. (2024). Does valve size impact hemodynamic, left ventricular mass regression, and prosthetic valve deterioration with a sutureless aortic valve?. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.01.017

Vancouver

Aldea GS, Burke CR, Fischlein T, Heimansohn DA, Haverich A, Suri RM, et al. Does valve size impact hemodynamic, left ventricular mass regression, and prosthetic valve deterioration with a sutureless aortic valve?. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2023.01.017

BibTeX
@article{Aldea2024,
  author = {Aldea, Gabriel S and Burke, Christopher R and Fischlein, Theodor and Heimansohn, David A and Haverich, Axel and Suri, Rakesh M and Ad, Niv},
  title = {Does valve size impact hemodynamic, left ventricular mass regression, and prosthetic valve deterioration with a sutureless aortic valve?},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  doi = {10.1016/j.jtcvs.2023.01.017}
}
Kostenlos starten →